Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001193125-25-045720
Filing Date
2025-03-04
Accepted
2025-03-04 17:17:15
Documents
2
Effectiveness Date
2025-03-04

Document Format Files

Seq Description Document Type Size
1 POS EX d908492dposex.htm POS EX 141397
2 EX-23.1 d908492dex231.htm EX-23.1 1568
  Complete submission text file 0001193125-25-045720.txt   143995
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-283150 | Film No.: 25706407
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)